v3.26.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 01, 2025
Jun. 03, 2024
Apr. 08, 2024
Apr. 01, 2023
Oct. 31, 2025
Jul. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Oct. 01, 2025
Dec. 30, 2024
Dec. 22, 2023
Feb. 23, 2023
Apr. 01, 2022
Common stock price per share             $ 1.90            
Proceeds from warrant exercises             $ 889,477          
Warrant liability             172,715          
Issued for services             304,800 138,979          
Officers compensation             615,284 662,554          
Forgiveness of debt - related party               13,886          
Accounts payable and accrued expenses             15,000            
Research and development expense         $ 527,625   $ 1,559          
Alteral Therapeutics [Member]                          
Equity method investment ownership percentage         49.90%                
Board of Directors Chairman [Member]                          
Officers compensation   $ 20,000                      
Director [Member]                          
Officers compensation   $ 10,000                      
NP Bioinnovation A/S [Member]                          
Ownership interest percentage                       100.00%  
Novi Thera [Member]                          
Ownership interest percentage         50.10%                
Darlington Group LLC [Member]                          
Advances on service fee                 $ 10,000        
GK Partners [Member]                          
Warrant to purchase common stock                   1,000,000     600,000
Warrant, exercise price                   $ 8.91     $ 10.00
Warrant expiration date                   Dec. 31, 2025 Dec. 31, 2024   Dec. 31, 2023
Number of unexercised warrant shares                     570,500    
Common stock issued on exercise of warrants               57,400          
Common stock price per share               $ 10.00          
Proceeds from warrant exercises               $ 576,000          
Common stock issued on exercise of warrants               35,176          
Proceeds from exercise of warrants               $ 313,455          
Warrant liability               $ 167,000          
GK Partners [Member] | Mag Mile Capital Inc [Member]                          
Common stock price per share             $ 5.00            
Number of shares purchased             49,000            
Gross proceeds             $ 245,000            
GK Partners [Member] | Minimum [Member]                          
Warrant, exercise price               $ 8.91          
GK Partners [Member] | Maximum [Member]                          
Warrant, exercise price               $ 8.95          
GK Partners Aps [Member]                          
Issued for services             126,658            
GK Partners Aps [Member] | Short Term Lease Agreement [Member]                          
Incurred expenses           $ 37,776              
Mr. Bennett Yankowitz [Member]                          
Legal fees             3,665 $ 79,463          
Due to related party             $ 0 $ 0          
Officers compensation $ 120,000   $ 60,000 $ 36,000                  
Employment agreement term       1 year                  
Employment agreement expiration date Jul. 01, 2026   Apr. 01, 2025                    
Henrik Rouf [Member]                          
Officers compensation $ 360,000   $ 120,000 $ 72,000                  
Employment agreement term       1 year                  
Employment agreement expiration date Jul. 01, 2026   Apr. 01, 2025